Literature DB >> 9719371

Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency.

D R Sjarif1, R J Sinke, M Duran, F A Beemer, W J Kleijer, J K Ploos van Amstel, B T Poll-The.   

Abstract

Isolated glycerol kinase deficiency (GKD) is an X linked recessive disorder. The clinical and biochemical picture may vary from a childhood metabolic crisis to asymptomatic adult "pseudohypertriglyceridaemia", the result of hyperglycerolaemia. We performed glycerol kinase (GK) gene analysis to study the molecular heterogeneity and genotype-phenotype correlation in eight males from three families with isolated GKD. All patients had hyperglycerolaemia and glyceroluria. Four patients from two families were essentially free of symptoms. Three patients had gastrointestinal symptoms with ketoacidosis or hypoglycaemia or both. One patient had recurrent convulsions as the only acute sign, without evidence that it was correlated with a catabolic state. Fasting tests in two symptomatic patients of family 1 showed hyperketotic states, together with a tendency to hypoglycaemia. The diagnosis was confirmed by a defective 14C-glycerol incorporation into trichloroacetic acid precipitable macromolecules in intact skin fibroblasts. Mutation screening of the GK gene was performed by amplification and direct sequencing of exons using PCR. Three novel mutations were identified: (1) a deletion starting downstream of exon 9, extending to the 3' end of the gene; (2) a nonsense mutation R413X caused by a C1351T transition; and (3) a missense mutation W503R caused by a T1651C transition. In addition, we found differences from the reported sequence: (1) exon 9 actually consists of two exons, which consequently will change the number of GK gene exons from 19 to 20 exons, and (2) nucleotide differences in exon 19. So far, no genotype-phenotype correlation can be established in these GKD families.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9719371      PMCID: PMC1051390          DOI: 10.1136/jmg.35.8.650

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Mutations and phenotype in isolated glycerol kinase deficiency.

Authors:  A P Walker; F Muscatelli; A N Stafford; J Chelly; N Dahl; H K Blomquist; J Delanghe; P J Willems; B Steinmann; A P Monaco
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  X-linked glycerol kinase deficiency in the mouse leads to growth retardation, altered fat metabolism, autonomous glucocorticoid secretion and neonatal death.

Authors:  A H Huq; R S Lovell; C N Ou; A L Beaudet; W J Craigen
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

3.  Isolation, mapping, and functional expression of the mouse X chromosome glycerol kinase gene.

Authors:  A H Huq; R S Lovell; M J Sampson; W K Decker; M B Dinulos; C M Disteche; W J Craigen
Journal:  Genomics       Date:  1996-09-15       Impact factor: 5.736

4.  The glycerol kinase gene family: structure of the Xp gene, and related intronless retroposons.

Authors:  C A Sargent; C Young; S Marsh; M A Ferguson-Smith; N A Affara
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

5.  Phenotypic features of patients with congenital adrenal hypoplasia and glycerol kinase deficiency.

Authors:  J E Wise; R Matalon; A M Morgan; E R McCabe
Journal:  Am J Dis Child       Date:  1987-07

6.  Regulation of gluconeogenesis by glycerol and its phosphorylated derivatives.

Authors:  R A Wapnir; L Stiel
Journal:  Biochem Med       Date:  1985-04

7.  Glycerol kinase deficiency in two brothers with and without clinical manifestations.

Authors:  H K Blomquist; N Dahl; L Gustafsson; C Hellerud; E Holme; G Holmgren; L Matsson; M von Zweigbergk
Journal:  Clin Genet       Date:  1996-11       Impact factor: 4.438

8.  Glycerol gluconeogenesis in fasting humans.

Authors:  H Baba; X J Zhang; R R Wolfe
Journal:  Nutrition       Date:  1995 Mar-Apr       Impact factor: 4.008

9.  Dysmorphic features in patients with complex glycerol kinase deficiency.

Authors:  A Scheuerle; F Greenberg; E R McCabe
Journal:  J Pediatr       Date:  1995-05       Impact factor: 4.406

10.  Human glycerol kinase deficiency: enzyme kinetics and fibroblast hybridization.

Authors:  E R McCabe; D Sadava; W W Bullen; H A McKelvey; W K Seltzer; C I Rose
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

View more
  6 in total

1.  Hyperketonaemia in glycerol kinase deficiency.

Authors:  D R Sjarif; L Dorland; W Sperl; T J de Koning; F A Beemer; B T Poll-The; M Duran
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

2.  Five cases of isolated glycerol kinase deficiency, including two families: failure to find genotype:phenotype correlation.

Authors:  C A Sargent; A Kidd; S Moore; J Dean; G T Besley; N A Affara
Journal:  J Med Genet       Date:  2000-06       Impact factor: 6.318

3.  Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait.

Authors:  D Gaudet; S Arsenault; L Pérusse; M C Vohl; J St-Pierre; J Bergeron; J P Després; K Dewar; M J Daly; T Hudson; J D Rioux
Journal:  Am J Hum Genet       Date:  2000-03-27       Impact factor: 11.025

Review 4.  Isolated and contiguous glycerol kinase gene disorders: a review.

Authors:  D R Sjarif; J K Ploos van Amstel; M Duran; F A Beemer; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 5.  Hypoglycaemia Metabolic Gene Panel Testing.

Authors:  Arianna Maiorana; Francesca Romana Lepri; Antonio Novelli; Carlo Dionisi-Vici
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

6.  Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita.

Authors:  M G Shaikh; L Boyes; H Kingston; R Collins; G T N Besley; B Padmakumar; O Ismayl; I Hughes; C M Hall; C Hellerud; J C Achermann; P E Clayton
Journal:  J Med Genet       Date:  2008-09       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.